Abstract

The interplay between 3D chromatin architecture and gene silencing is incompletely understood. Here, we report a novel point mutation in the non-canonical SMC protein SMCHD1 that enhances its silencing capacity at endogenous developmental targets. Moreover, it also results in enhanced silencing at the facioscapulohumeral muscular dystrophy associated macrosatellite-array, D4Z4, resulting in enhanced repression of DUX4 encoded by this repeat. Heightened SMCHD1 silencing perturbs developmental Hox gene activation, causing a homeotic transformation in mice. Paradoxically, the mutant SMCHD1 appears to enhance insulation against other epigenetic regulators, including PRC2 and CTCF, while depleting long range chromatin interactions akin to what is observed in the absence of SMCHD1. These data suggest that SMCHD1’s role in long range chromatin interactions is not directly linked to gene silencing or insulating the chromatin, refining the model for how the different levels of SMCHD1-mediated chromatin regulation interact to bring about gene silencing in normal development and disease.

Here the authors reveal that a neomorphic mutation in chromatin protein SMCHD1 enhances SMCHD1-mediated gene silencing, including at the FSHD disease-relevant locus, while depleting SMCHD1-mediated chromatin interactions, suggesting these SMCHD1 functions are unlinked.

Details

Title
SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease
Author
Tapia del Fierro, Andres 1   VIAFID ORCID Logo  ; den Hamer, Bianca 2 ; Benetti, Natalia 1   VIAFID ORCID Logo  ; Jansz, Natasha 1   VIAFID ORCID Logo  ; Chen, Kelan 1 ; Beck, Tamara 3 ; Vanyai, Hannah 4 ; Gurzau, Alexandra D. 1 ; Daxinger, Lucia 5   VIAFID ORCID Logo  ; Xue, Shifeng 6   VIAFID ORCID Logo  ; Ly, Thanh Thao Nguyen 6 ; Wanigasuriya, Iromi 1 ; Iminitoff, Megan 1 ; Breslin, Kelsey 3   VIAFID ORCID Logo  ; Oey, Harald 5 ; Krom, Yvonne D. 2 ; van der Hoorn, Dinja 2 ; Bouwman, Linde F. 2   VIAFID ORCID Logo  ; Johanson, Timothy M. 1 ; Ritchie, Matthew E. 1   VIAFID ORCID Logo  ; Gouil, Quentin A. 1   VIAFID ORCID Logo  ; Reversade, Bruno 7   VIAFID ORCID Logo  ; Prin, Fabrice 4 ; Mohun, Timothy 4 ; van der Maarel, Silvère M. 2   VIAFID ORCID Logo  ; McGlinn, Edwina 8   VIAFID ORCID Logo  ; Murphy, James M. 9   VIAFID ORCID Logo  ; Keniry, Andrew 1   VIAFID ORCID Logo  ; de Greef, Jessica C. 2   VIAFID ORCID Logo  ; Blewitt, Marnie E. 1   VIAFID ORCID Logo 

 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889); University of Melbourne, The Department of Medical Biology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Leiden University Medical Center, Department of Human Genetics, Leiden, Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978) 
 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889) 
 The Francis Crick Institute, Crick Advanced Light Microscopy Facility, London, UK (GRID:grid.451388.3) (ISNI:0000 0004 1795 1830) 
 Queensland Institute of Medical Research, Brisbane, Australia (GRID:grid.1049.c) (ISNI:0000 0001 2294 1395) 
 National University of Singapore, Department of Biological Sciences, Singapore, Singapore (GRID:grid.4280.e) (ISNI:0000 0001 2180 6431); Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243) 
 Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore (GRID:grid.418812.6) (ISNI:0000 0004 0620 9243); Genome Institute of Singapore, A*STAR, Singapore, Singapore (GRID:grid.418377.e) (ISNI:0000 0004 0620 715X) 
 Monash University, EMBL Australia, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash University, Australian Regenerative Medicine Institute, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
 The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia (GRID:grid.1042.7) (ISNI:0000 0004 0432 4889); University of Melbourne, The Department of Medical Biology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X); Monash University, Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857) 
Pages
5466
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2868491140
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.